Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains

HMA Hameed, MM Islam, C Chhotaray… - Frontiers in cellular …, 2018 - frontiersin.org
Tuberculosis (TB) is a formidable infectious disease that remains a major cause of death
worldwide today. Escalating application of genomic techniques has expedited the …

Multidrug resistance (MDR) and collateral sensitivity in bacteria, with special attention to genetic and evolutionary aspects and to the perspectives of antimicrobial …

A Fodor, BA Abate, P Deák, L Fodor, E Gyenge… - Pathogens, 2020 - mdpi.com
Antibiotic poly-resistance (multidrug-, extreme-, and pan-drug resistance) is controlled by
adaptive evolution. Darwinian and Lamarckian interpretations of resistance evolution are …

Novel strategies to combat the emerging drug resistance in human pathogenic microbes

H Qadri, AH Shah, M Mir - Current drug targets, 2021 - ingentaconnect.com
The major health-care burden for the developing world are infectious diseases where
antimicrobial agents prove to be the magical drugs to combat this. But the phenomenon of …

Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China

Q Liu, D Yang, B Qiu, L Martinez, Y Ji… - PLoS Neglected …, 2021 - journals.plos.org
Background Multidrug-resistant tuberculosis (MDR-TB) poses a serious challenge to TB
control. It is of great value to search for drug resistance mutation sites and explore the roles …

Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis

C Lange, WA Alghamdi, MH Al‐Shaer… - Journal of internal …, 2018 - Wiley Online Library
Abstract According to the World Health Organization (WHO), tuberculosis is the leading
cause of death attributed to a single microbial pathogen worldwide. In addition to the large …

Impact of Whole-Genome Sequencing of Mycobacterium tuberculosis on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review

D Hazra, C Lam, K Chawla, V Sintchenko, VS Dhyani… - Pharmaceutics, 2023 - mdpi.com
The emergence and persistence of drug-resistant tuberculosis is a major threat to global
public health. Our objective was to assess the applicability of whole-genome sequencing …

Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait

NM Al-Mutairi, S Ahmad, E Mokaddas - Scientific Reports, 2021 - nature.com
Molecular methods detect genetic mutations associated with drug resistance. This study
detected resistance-conferring mutations in gyrA/gyrB for fluoroquinolones and rrs/eis genes …

GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput …

JMW Pinhata, AP Brandao, JF Gallo… - … and Infectious Disease, 2023 - Elsevier
We assessed the performance of MTBDRsl for detection of resistance to fluoroquinolones,
aminoglycosides/cyclic peptides, and ethambutol compared to BACTEC MGIT 960 by …

Treatment of drug-resistant tuberculosis among people living with HIV

RM Hurtado, D Meressa… - Current opinion in HIV and …, 2018 - journals.lww.com
The clinical complexity of co-managing drug-resistant TB and HIV, and the higher rate of
poor treatment outcomes in this population demand careful clinical management strategies …

Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates

C Teng, L Li, D Su, H Li, B Zhao, H Xia, H Teng, Y Song… - Heliyon, 2024 - cell.com
Objective To detect levofloxacin (LFX) and moxifloxacin (MFX) resistance among rifampicin-
resistant tuberculosis (RR-TB) isolates, and predict the resistance level based on specific …